Our scientists excel in designing high-throughput screening (HTS) campaigns that go beyond identifying potential hits to deliver lead-like compounds that meet your desired profile. For hits from cell-based HTS, understanding the mode of action is crucial. We offer follow-up assays to elucidate the nature of compound-target interactions and provide essential insights for informed decision-making.
Explore our portfolio of cell model generation capabilities.
learn moreThis flyer summarises Nuvisan’s expertise in using human iPSCs as in vitro models to recapitulate complex human biology.
downloadWe develop a wide range of HTS-compatible cell-based assays, including classical end-point assays, kinetic readouts and high-content analyses.
learn more